new research shows a growing number of young people are thinking about taking their own lives, and the study suggests school stress may play a role.
.
..
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
.
.
..